Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MTX-211, an inhibitor of EGFR and PI3K, is used for the therapy of cancer and other diseases.
説明 | MTX-211, an inhibitor of EGFR and PI3K, is used for the therapy of cancer and other diseases. |
別名 | MTX 211 |
分子量 | 478.33 |
分子式 | C20H14Cl2FN5O2S |
CAS No. | 1952236-05-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 15 mg/mL (31.36 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MTX-211 1952236-05-3 Angiogenesis JAK/STAT signaling PI3K/Akt/mTOR signaling Tyrosine Kinase/Adaptors PI3K EGFR Mol211 MTX211 Phosphoinositide 3-kinase Mol-211 Inhibitor quinazoline derivatives cancer phosphoinositide 3 ' OH kinase family (PIK3) the epidermal growth factor EGFR family ErbB-1 MTX 211 HER1 Mol 211 inhibit Epidermal growth factor receptor inhibitor